“Safety Profile of 5% Albumin Versus Fresh Frozen Plasma in Therapeutic Plasma Exchange for Guillain-Barré Syndrome” (2026) The Planet, 9(2), pp. 9–13. doi:10.5281/zenodo.19497028.